Not applicableStudy completedNCT02664389
What this trial is testing
Targeted Next-generation Sequencing Panel for Identification of Germline Mutations in Early Onset Cancers With Sporadic or Hereditary Presentation
Who this might be right for
Breast CancerOvarian CancerColorectal Cancer+2 more
University Hospital, Rouen 289